Page last updated: 2024-09-03

sc 51089 and tyrosine

sc 51089 has been researched along with tyrosine in 1 studies

Compound Research Comparison

Studies (sc 51089)	Trials (sc 51089)	Recent Studies (post-2010) (sc 51089)	Studies (tyrosine)	Trials (tyrosine)	Recent Studies (post-2010) (tyrosine)
41	1	19	44,273	846	8,225

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukumoto, K; Moriyama, Y; Takagi, N; Takeo, S; Tanonaka, K; Yamamoto, R	1

Other Studies

1 other study(ies) available for sc 51089 and tyrosine

Article	Year
Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia. European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3 Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillaries; Capillary Permeability; Fluorescein-5-isothiocyanate; Hydrazines; Male; Membrane Proteins; Occludin; Oxazepines; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Serum Albumin; Tyrosine	2010

Article

Year

Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia.

European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillaries; Capillary Permeability; Fluorescein-5-isothiocyanate; Hydrazines; Male; Membrane Proteins; Occludin; Oxazepines; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Serum Albumin; Tyrosine

2010